LONDON – The Covid-19 is probably as “endemic” as the annual influenza virus, according to the UK’s leading clinical advisor.
Some prospective vaccines are at a complex level of clinical trials, however, Patrick Vallance said that most likely none will eliminate the virus.
“The perception of getting rid of Covid from anywhere is not fair, because he will come back,” he said, noting that there had only been one human disease “really eradicated” thanks to a highly effective vaccine and that smallpox.
“We can’t be sure, but I think it’s highly unlikely that we’ll end up with a really sterilizing vaccine (i. e. , anything that stops the infection altogether, and chances are this disease will circulate and “Be finishemic, that’s my most productive assessment,” Vallance told the National Security Strategy Committee in London on Monday.
“Obviously, as you improve control, as you get vaccinated, which would reduce the threat of infection and the severity of the disease. Array. . . then it starts to look more like an annual flu than anything else, and that would possibly be the direction we’re going to finish going,” he said.
Biotechnology corporations and educational organizations around the world have teamed up to try to create a coronavirus vaccine at breakneck speed given its ferocity. On Monday, the bleak 40 million milestone showed cases of coronavirus hit worldwide and the virus caused 1. 1 million deaths. , according to the knowledge of Johns Hopkins University.
Historically, creating a vaccine from scratch had taken an average of 10 years, Vallance said, and had never taken less than years.
“We are now in an ordinary scenario where there are at least 8 vaccines that are the subject of quite significant clinical studies around the world. (. . . ) We’ll know in the coming months if we have vaccines that protect and how long they protect,” he says.
He added that several vaccines have created an immune reaction and an antibody reaction, however, only Phase 3 clinical trials would result if they “actually prevent others from becoming infected. “The protection profile of these vaccines would also be clearer and then it can be considered a “sensible vaccination strategy,” Vallance said.
Vallance concluded that there would not be a vaccine available for widespread use on the network until at least spring.
Do you have any confidential information? We want to hear from you.
Sign up for loose newsletters and get more CNBC in your inbox
Get it in your inbox and more information about our services.
© 2020 CNBC LLC. All rights are reserved. An NBCUniversal department
Knowledge is a real-time snapshot: data is delayed for at least 15 minutes, monetary and global industry news, inventory quotes, and market knowledge and analysis.
Data also by